SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000885590-12-000060
Filing Date
2012-10-02
Accepted
2012-10-02 16:45:58
Documents
1
Period of Report
2012-09-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3352
  Complete submission text file 0000885590-12-000060.txt   4937
Mailing Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9
Business Address 4787 LEVY STREET MONTREAL QUEBEC A8 H4R 2P9 514-744-6792
Valeant Pharmaceuticals International, Inc. (Issuer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 81 WYMAN ST POST OFFICE BOX 9046 WALTHAM MA 02454
Business Address
MELAS KYRIAZI THEO (Reporting) CIK: 0001216078 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-14956 | Film No.: 121124143